Countries Europe

CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...

 July 17, 2024 | News

Accelerated Biosciences and Pluristyx Achieve Breakthrough in Creating Clinical Grade iPSC Lines Using Novel hTSC Starting Material

Accelerated Biosciences ("Accelerated Bio"), in partnership with Pluristyx, proudly announces the successful creation of clinical grade induced pluripotent...

 July 15, 2024 | News

Aptamer Group and AstraZeneca Collaborate to Advance Targeted siRNA Delivery for Fibrotic Liver Cells

  Aptamer Group , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce a new agreem...

 July 05, 2024 | News

Eppendorf Award for Young European  Investigators 2024 goes to Clemens Plaschka,  Austria 

  Clemens Plaschka, born 1989, receives the 20,000 euro award for his  research on the molecular machines that generate and export messenger&nbs...

 July 04, 2024 | News

Celonic Group Expands Biologics Process Development with New Basel Facility

The Celonic Group, a “Pure Play” Biologics Contract Development Organization (CDMO) expands process development and optimization services in ...

 June 19, 2024 | News

SciRhom GmbH Secures Approval for Clinical Trial Application of SR-878 in Austria

SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic antibodies, announced the approval of a clinical trial a...

 June 14, 2024 | News

Freudenberg Medical Invests Over $50 Million in New Hemoteq Production Facility in Germany

Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry...

 June 12, 2024 | News

Merck Opens Expanded Life Science Distribution Center in Germany

Expands facility by 25,000 square meters, nearly doubling size Adds new down filling capabilities and distribution space for Life Science customers Emp...

 June 07, 2024 | News

Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...

 June 03, 2024 | News

Thermo Fisher Scientific Announces IVDR Compliance for CytoScan Dx Assay and ChAS Dx Software, Enhancing Cytogenetic Testing in the EU

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied...

 May 31, 2024 | News

ProBioGen and ModeX Therapeutics Partner to Accelerate Development of Multi-Specific COVID-19 Antibody

 ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and bioproces...

 May 30, 2024 | News

Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test

Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...

 May 22, 2024 | News

Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies

  The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...

 May 01, 2024 | News

Pfizer and Genmab's TIVDAK Wins FDA Full Approval for Cervical Cancer After Outperforming Chemotherapy in Key Trial

TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastat...

 April 30, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close